Major Growth Boosting Factors:
The increasing government funding for cell-based research, the increasing number of patients suffering from cancer and infectious diseases, technological advancements, and the growing focus on personalized medicine are the major factors driving the cell isolation markets growth. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the cell isolation market.
Expected Revenue Surge:
The global Cell Isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9 billion in 2020, at a 16.8% CAGR.
This study involved four major activities in estimating the current size of the cell isolation market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments’ market size.
Download PDF Brochure@
In 2019, consumables segment accounted for the largest share of the cell isolation market, by product
Based on product, the cell isolation market is segmented into consumables and instruments. The consumables segment accounted for the largest share in the cell isolation market in 2019. The increasing investments by companies to develop technologically advanced products as well as the repetitive use of consumables as compared to instruments are the major factors driving the growth of this segment.
In 2019, bone marrow segment accounted for the largest share in the market, by cell source
The cell isolation market is segmented into bone marrow, adipose tissue and cord blood/ embryonic stem cells. In 2019, the bone marrow segment accounted for the largest share. Over the last decade, the market has witnessed the commercialization of a number of bone marrow-derived stem cell-based products for various therapeutic applications, including cardiovascular disease treatment, tissue regeneration, and musculoskeletal disorders which has supported overall growth in this segment.
In 2019, biotechnology and biopharmaceutical companies segment accounted for the largest share in the market, by end user
The cell isolation market is segmented into hospitals and diagnostic laboratories, biotechnology and biopharmaceutical companies, research laboratories and institutes, and other end users based on end users. In 2019, the biotechnology and biopharmaceutical companies segment accounted for the largest share. The large share of this end-user segment can be attributed to the widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology and biopharmaceutical companies, as well as the increasing number of R&D facilities globally.
North America is the largest regional market for cell isolation market
The cell isolation market is segmented into four regions, namely, North America, Europe, Asia Pacific and Rest of the world. In 2019, North America accounted for the largest share of the cell isolation market. The large share of North America can be attributed to technological advancements, growth in the biotechnology and pharmaceutical industries, increasing prevalence of chronic and infectious diseases, and higher investments in cell-based research in the region.
The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company Limited (US), Beckman Coulter Inc. (US).Merck KGaA (Germany), Terumo BCT (Japan), GE Healthcare (US), Bio- Rad Laboratories Inc. (US), Corning Inc. (US), Roche Diagnostics (Switzerland, Alfa Laval (Sweden), Miltenyl Biotech (Germany), pluriSelect Life Science (Germany), STEMCELL Technologies Inc. (Canada), Akadeum Life Sciences, Inc (US), Bio- Techne (US), Bio Legend (US) and Invent Biotechnologies (US).
Request Sample Pages@